Japan Biological Implants Market Size & Outlook, 2023-2030

The biological implants market in Japan is expected to reach a projected revenue of US$ 792.9 million by 2030. A compound annual growth rate of 7.8% is expected of Japan biological implants market from 2024 to 2030.
Revenue, 2023 (US$M)
$468.0
Forecast, 2030 (US$M)
$792.9
CAGR, 2024 - 2030
7.8%
Report Coverage
Japan

Japan biological implants market highlights

  • The Japan biological implants market generated a revenue of USD 468.0 million in 2023 and is expected to reach USD 792.9 million by 2030.
  • The Japan market is expected to grow at a CAGR of 7.8% from 2024 to 2030.
  • In terms of segment, xenografts was the largest revenue generating product in 2023.
  • Autografts is the most lucrative product segment registering the fastest growth during the forecast period.


Biological implants market data book summary

Market revenue in 2023USD 468.0 million
Market revenue in 2030USD 792.9 million
Growth rate7.8% (CAGR from 2023 to 2030)
Largest segmentXenografts
Fastest growing segmentAutografts
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAutografts, Allografts, Xenografts
Key market players worldwideIntegra Lifesciences Holdings Corp, Globus Medical Inc Class A, Edwards Lifesciences Corp, Stryker Corp, Medtronic PLC, Johnson & Johnson, Baxter International Inc, Vericel Corp, Alphatec Holdings Inc, Artivion Inc, Conmed Corp, AbbVie Inc, MiMedx Group Inc, Organogenesis Holdings Inc Class A, Smith & Nephew PLC, LifeCell International, Osteotec, RTI Surgical - OEM Business, Isis Biopolymer, Implandata Ophthalmic Products, BioTissue, Auto Tissue


Other key industry trends

  • In terms of revenue, Japan accounted for 5.6% of the global biological implants market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan biological implants market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 441.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biological Implants Market Companies

Name Profile # Employees HQ Website

Japan biological implants market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological implants market will help companies and investors design strategic landscapes.


Xenografts was the largest segment with a revenue share of 50.28% in 2023. Horizon Databook has segmented the Japan biological implants market based on autografts, allografts, xenografts covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Japan biological implants market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan biological implants market databook

  • Our clientele includes a mix of biological implants market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan biological implants market , including forecasts for subscribers. This country databook contains high-level insights into Japan biological implants market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan biological implants market size, by product, 2018-2030 (US$M)

Japan Biological Implants Market Outlook Share, 2023 & 2030 (US$M)

Japan biological implants market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more